Effects of combined oral contraceptive ethinylestradiol (30g) and dienogest (2mg) on carbohydrate metabolism during 1 year of conventional or extended-cycle use

Hormone and Metabolic Research

Volumn 42, Issue 5, 2010, Pages 358-363

  Wiegratz, I ^a   Stahlberg, S ^a   Manthey, T ^a   Snger, N ^a   Mittmann, K ^b   Palombo Kinne, E ^b   Mellinger, U ^b   Lange, E ^b   Kuhl, H ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

C peptide; Combined oral contraceptives; Extended cycle regimen; Glucose metabolism; Glucose tolerance; Insulin

Indexed keywords

C PEPTIDE; DIENOGEST; ETHINYLESTRADIOL; GLUCOSE; HEMOGLOBIN A1C; LEVOTHYROXINE; METHYLPREDNISOLONE;

ADULT; ARTICLE; BLOOD SAMPLING; CARBOHYDRATE METABOLISM; CONTROL GROUP; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOTHYROIDISM; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BLOOD GLUCOSE; C-PEPTIDE; CARBOHYDRATE METABOLISM; CONTRACEPTIVES, ORAL, HORMONAL; ETHINYL ESTRADIOL; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN RESISTANCE; MENSTRUATION; NANDROLONE; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77951988041     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0030-1248263     Document Type: Article

References (29)

1. Wynn V, Godsland I, Niththyananthan R, Adams PW, Melrose J, Oakley NW, Seed M. Comparison of effects of different combined oral-contraceptive formulations on carbohydrate and lipid metabolism. Lancet 1979 19 1045-1049 (Pubitemid 9177133)
2. Godsland IF. The influence of female sex steroids on glucose metabolism and insulin action. J Intern Med 1996 240 1-65
3. Gaspard UJ. Metabolic effects of oral contraceptives. Am J Obstet Gynecol 1987 157 1029-1041
4. Crook D, Godsland I. Safety evaluation of modern oral contraceptives. Contraception 1998 57 189-201
5. Godsland IF, Crook D, Stevenson J, Wynn V. Estrogen/progestin combinations and carbohydrate metabolism. Int Proc J 1989 1 74-80
6. Wiegratz I, Kuhl H. Long-cycle treatment with oral contraceptives. Drugs 2004 64 2447-2462
7. Sulak PJ, Kuehl TJ, Ortiz M, Shull BL. Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms. Am J Obstet Gynecol 2002 186 1142-1149 (Pubitemid 34665050)
8. Jung-Hoffmann C, Kuhl H. Pharmacokinetics and pharmacodynamics of oral contraceptive steroids: factors influencing steroid metabolism. Am J Obstet Gynecol 1990 163 2183-2197
9. Wiegratz I, Hommel HH, Zimmermann T, Kuhl H. Attitudes of German women and gynecologists towards long-cycle treatment with oral contraceptives. Contraception 2004 69 37-42 (Pubitemid 38076964)
10. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004 27 1487-1495
11. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 1999 22 1462-1470
12. Song S, Chen JK, Yang PJ, He ML, Li LM, Fan BC, Rekers H, Fotherby K. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel. Contraception 1992 45 523-532
13. Oelkers W, Foidart JM, Dombrovicz N, Welter A, Heithecker R. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism. J Clin Endocrinol Metab 1995 80 1816-1821
14. Rubeck Petersen K, Skouby SO, Gronholt Pedersen R. Desogestrel and gestodene in oral contraceptives: 12 months assessment of carbohydrate and lipoprotein metabolism. Obstet Gynecol 1991 78 666-672
15. Kuhl H, Jung-Hoffmann C, Weber J, Boehm BO. The effect of a biphasic desogestrel-containing oral contraceptive on carbohydrate metabolism and various hormonal parameters. Contraception 1993 47 55-68 (Pubitemid 23041432)
16. Knopp RH, Broyles FE, Cheung M, Moore K, Marcovina S, Chandler WL. Comparison of the lipoprotein, carbohydrate, and hemostatic effects of phasic oral contraceptives containing desogestrel or levonorgestrel. Contraception 2001 63 1-11 (Pubitemid 32232176)
17. Gaspard U, Scheen A, Endrikat J, Buicu C, Lefebvre P, Gerlinger C, Heithecker R. A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism. Contraception 2003 67 423-429 (Pubitemid 36695106)
18. Troisi RJ, Cowie CC, Harris MI. Oral contraceptive use and glucose metabolism in a national sample of women in the United states. Am J Obstet Gynecol 2000 183 389-395
19. Godsland IF, Crook D, Simpson R, Proudler T, Felton C, Lees B, Anyaoku V, Devenport M, Wynn V. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N Engl J Med 1990 323 1375-1381
20. Endrikat J, Klipping C, Cronin M, Gerlinger C, Ruebig A, Schmidt W, Dsterberg B. An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20g ethinyl estradiol and 100g levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variables. Contraception 2002 65 215-221 (Pubitemid 34258542)
21. Ldicke F, Gaspard UJ, Demeyer F, Scheen A, Lefebvre P. Randomized controlled study of the influence of two low estrogen dose oral contraceptives containing gestodene or desogestrel on carbohydrate metabolism. Contraception 2002 66 411-415 (Pubitemid 37338056)
22. Kuhl H, Gahn G, Romberg G, Althoff PH, Taubert HD. A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic serum parameters: II. Effects upon thyroid function, gastrin, STH, and glucose tolerance. Contraception 1985 32 97-107 (Pubitemid 15227622)
23. Skouby SO, Endrikat J, Dsterberg B, Schmidt W, Gerlinger C, Wessel J, Goldstein H, Jespersen J. A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20g ethinyl estradiol combined with 100g levonorgestrel. Contraception 2005 71 111-117 (Pubitemid 40222063)
24. Bonassi Machado R, Fabrini P, Machado Cruz A, Maia E, da Cunha Bastos A. Clinical and metabolic aspects of the continuous use of contraceptive association of ethinyl estradiol (30g) and gestodene (75g). Contraception 2004 70 365-370 (Pubitemid 39422512)
25. The Expert Committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2002 25 S5-S20 (Pubitemid 41185039)
26. Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008 294 E15-E26
27. Jarret RJ, Graver HJ. Changes in oral glucose tolerance during the menstrual cycle. BMJ 1968 2 528-529
28. Cagnacci A, Paoletti AM, Renzi A, Orru M, Pilloni M, Melis GB, Volpe A. Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel. J Clin Endocrinol Metab 2003 88 3621-3625 (Pubitemid 37034504)
29. Godsland IF, Walton C, Felton C, Proudler A, Patel A, Wynn V. Insulin resistance, secretion, and metabolism in users of oral contraceptives. J Clin Endocrinol Metab 1991 74 64-70